Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
National Institutes of Health · PAR-25-265 · Research funding opportunity
Overview
Supports development of screening methods or early treatments for serious conditions identified through newborn screening, including high-priority genetic disorders that could become screenable. Projects should establish the value of early detection or intervention.
Eligibility
Wits may apply as a non-US higher education institution. Proposals must fit this call and the mission of a participating institute; institutional registrations and funder requirements apply.
Other deadlines
Next new-application deadline: 5 October 2026. Next renewal/resubmission/revision deadline, where permitted: 5 November 2026. Submit by 17:00 local time of the applicant organisation. Call expiration: 17 November 2027. This is separate from the application deadline.